Jane Street’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Jane Street’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-44,700	Closed	-$668K	–	10609
2022 Q4	$668K	Buy	+44,700	New	+$619K	﹤0.01%	5651
2022 Q1	–	Sell	-19,300	Closed	-$91K	–	11537
2021 Q4	$91K	Sell	19,300 -8,800	-31%	-$54.6K	﹤0.01%	9301
2021 Q3	$174K	Sell	28,100 -17,900	-39%	-$107K	﹤0.01%	8955
2021 Q2	$303K	Sell	46,000 -28,500	-38%	-$196K	﹤0.01%	8135
2021 Q1	$545K	Buy	+74,500	New	+$643K	﹤0.01%	6646

Jane Street's AVEO Position: Q1 2023 in Review

Jane Street sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 80,874 shares — an estimated $1.21M sold.

Jane Street first reported a position in AVEO in Q2 2013 and held it in 13 quarters. The position peaked at $1.21M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Jane Street reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Jane Street sold 80,874 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.21M.
Jane Street first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
Jane Street's AVEO Pharmaceuticals, Inc. position peaked at $1.21M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.